Clinical Trials Logo

Filter by:
NCT ID: NCT05686096 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435

Start date: January 16, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the absorption, metabolism, excretion; and to evaluate the safety and tolerability of BMS-986435 in healthy male participants Participants will be admitted to the study site for 3 weeks.

NCT ID: NCT05686083 Completed - Pharmacokinetics Clinical Trials

Pharmacokinetics of Two Fatty Acid Ketone Esters

Start date: January 30, 2023
Phase: N/A
Study type: Interventional

Randomized, cross over pharmacokinetic study of a novel ketone di-ester and C6 ketone di-ester in ready to drink beverage matrices.

NCT ID: NCT05686044 Completed - Alzheimer Disease Clinical Trials

A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

Start date: April 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to measure efficacy and safety of three different doses of buntanetap/Posiphen compared with placebo in participants with mild to moderate Alzheimer's disease. Study details include: The double-blind treatment duration will include a screening period of up to 42 days followed by 12 weeks of treatment at home. The study duration will be 4-5 months. There will be 4 in-clinic visits and 1 phone call.

NCT ID: NCT05685758 Completed - Depression Clinical Trials

A Treatment for Depression Via a Gamified Mobile Phone Application Based on a New Cognitive Model

FTP
Start date: November 3, 2022
Phase: N/A
Study type: Interventional

The study is a randomized controlled treatment study comparing changes in depressive symptoms over 8 weeks between individuals with Major Depressive Disorder (MDD) who have access to an FTP-based mobile phone application and a control group not engaging with the app. FTP, the process of Facilitating Thought Progression, trains the brain's cognitive thought process to expand, accelerate, and be more creative, to alleviate depressive symptoms.

NCT ID: NCT05685407 Completed - Clinical trials for Female Sexual Arousal Disorder

Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women

Start date: January 1, 2023
Phase: Phase 1
Study type: Interventional

Antidepressants have negative effects on genital arousal function that hinder quality of life and jeopardize medication adherence. Moderate sympathetic nervous system (SNS) activation through exercise has shown promising results for improving antidepressant-induced genital arousal dysfunction. It is feasible that caffeine - an SNS stimulant - could improve antidepressant-induced genital arousal difficulties if ingested prior to sex. The goal of the present pilot study is to examine whether the acute administration of 300mg of caffeine increases genital arousal in women experiencing antidepressant-induced genital arousal difficulties. Women will attend two counterbalanced sessions in which they ingest either 300mg caffeine or placebo. Fifteen minutes after ingestion, they will view an erotic film while their heart rate and genital sexual arousal are measured. Caffeine could serve as a low-cost, widely accessible intervention with minimal side effects if efficacy is shown.

NCT ID: NCT05685082 Completed - Nurse's Role Clinical Trials

Teaching the Social Determinants of Health to Nursing Students With Simulation

Start date: February 2, 2023
Phase: N/A
Study type: Interventional

The goal of this intervention study is to compare two different simulation modalities (standardized patient and manikin-based) in nursing student education. The main aim is to determine the effect of new scenarios on cultural awareness levels in two different types of simulation modalities and to determine the effect of new scenarios on social determinants of health knowledge levels in two different types of simulation modalities. Participants will assign to two groups and will attend simulation sessions.

NCT ID: NCT05684640 Completed - Healthy Clinical Trials

A Single and Multiple Dose of Rodatristat Ethyl in Healthy Adult Subjects to Evaluate the Effect of Food and Safety

Start date: September 29, 2022
Phase: Phase 1
Study type: Interventional

This is a single and multiple dose food effect study of rodatristat ethyl in healthy subjects

NCT ID: NCT05684289 Completed - Clinical trials for Healthy Participants

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Start date: January 3, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, drug levels and drug effect of BMS-986278 in healthy adult participants and Japanese participants.

NCT ID: NCT05684133 Completed - Sepsis Clinical Trials

REMISE Study: REMnant Biospecimen Investigation in SEpsis

REMISE
Start date: October 25, 2022
Phase:
Study type: Observational

In the REMISE is study, we will compare blood proteins, biomarkers, and other -omics prospectively collected from patients with sepsis from two sources, i.) remnant (discarded) samples from the clinical laboratory, and ii.) prospectively collected in UPMC Presbyterian hospital research coordinator specimen collected biospecimens. Analyses will include traditional biomarkers, quantitative proteomics, metabolomics, lipidomics, transcriptomics, and pathogen genomic sequencing in both sets of samples. This data will allow the assessment of the feasibility, integrity, and scientific value of remnant samples compared to research coordinator samples collected at the bedside for mechanistic sepsis research.

NCT ID: NCT05684016 Completed - Clinical trials for Multiple Sclerosis, Relapsing-Remitting

Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM

NeuroQuant
Start date: December 2013
Phase: N/A
Study type: Interventional

The purpose of the research study is to investigate whether the extent and severity of lesions in the brain as measured by special MRI techniques can distinguish between Multiple Sclerosis (MS) patients with or without memory impairment and also between MS patients and age matched healthy controls.